Bulk Manufacturer of Controlled Substances Application: Curia Wisconsin, Inc., 79950 [2024-22446]
Download as PDF
<![CDATA[
79950
Federal Register / Vol. 89, No. 190 / Tuesday, October 1, 2024 / Notices
produced in each Subject Country, and
such merchandise from other countries.
(13) (OPTIONAL) A statement of
whether you agree with the above
definitions of the Domestic Like Product
and Domestic Industry; if you disagree
with either or both of these definitions,
please explain why and provide
alternative definitions.
Authority: This proceeding is being
conducted under authority of Title VII
of the Tariff Act of 1930; this notice is
published pursuant to § 207.61 of the
Commission’s rules.
By order of the Commission.
Issued: September 25, 2024.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2024–22441 Filed 9–30–24; 8:45 am]
BILLING CODE 7020–02–P
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on August 22, 2024, Curia
Wisconsin, Inc., 870 Badger Circle,
Grafton, Wisconsin 53024–0000,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
ADDRESSES:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1434]
Bulk Manufacturer of Controlled
Substances Application: Curia
Wisconsin, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Curia Wisconsin, Inc., has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplementary Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before December 2, 2024. Such
persons may also file a written request
for a hearing on the application on or
before December 2, 2024.
SUMMARY:
Controlled substance
Drug code
khammond on DSKJM1Z7X2PROD with NOTICES
Lysergic acid diethylamide .....................................................................................................................................................
Tetrahydrocannabinols ...........................................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine .................................................................................................................................
3,4-Methylenedioxyamphetamine ...........................................................................................................................................
3,4-Methylenedioxymethamphetamine ...................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine ........................................................................................................................................
Dimethyltryptamine .................................................................................................................................................................
Psilocybin ...............................................................................................................................................................................
Psilocyn ..................................................................................................................................................................................
Lisdexamfetamine ..................................................................................................................................................................
Methylphenidate .....................................................................................................................................................................
Amobarbital ............................................................................................................................................................................
Nabilone .................................................................................................................................................................................
4-Anilino-N-Phenethyl-4-Piperidine (ANPP) ...........................................................................................................................
Opium extracts .......................................................................................................................................................................
Opium, powdered ...................................................................................................................................................................
Opium, granulated ..................................................................................................................................................................
Opium poppy ..........................................................................................................................................................................
Noroxymorphone ....................................................................................................................................................................
Fentanyl ..................................................................................................................................................................................
The company plans to bulk
manufacture the listed controlled
substances for the purpose of analytical
reference standards or for sale to its
customers. In reference to the drug code
7370 (Tetrahydrocannabinols), the
company plans to bulk manufacture as
synthetic. No other activities for these
drug codes are authorized for this
registration.
DEPARTMENT OF JUSTICE
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
ACTION:
[FR Doc. 2024–22446 Filed 9–30–24; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
17:42 Sep 30, 2024
Jkt 265001
[Docket No. DEA–1435]
Importer of Controlled Substances
Application: Fresenius Kabi USA, LLC
Drug Enforcement
Administration, Justice.
AGENCY:
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before October 31, 2024. Such
persons may also file a written request
for a hearing on the application on or
before October 31, 2024.
DATES:
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
ADDRESSES:
Fresenius Kabi USA, LLC has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplementary
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
Information listed below for further
drug information.
Drug Enforcement Administration
SUMMARY:
7315
7370
7392
7400
7405
7431
7435
7437
7438
1205
1724
2125
7379
8333
9610
9639
9640
9650
9668
9801
Schedule
E:\FR\FM\01OCN1.SGM
01OCN1
]]>Agencies
[Federal Register Volume 89, Number 190 (Tuesday, October 1, 2024)]
[Notices]
[Page 79950]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-22446]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1434]
Bulk Manufacturer of Controlled Substances Application: Curia
Wisconsin, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Curia Wisconsin, Inc., has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants, therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
December 2, 2024. Such persons may also file a written request for a
hearing on the application on or before December 2, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on August 22, 2024, Curia Wisconsin, Inc., 870 Badger
Circle, Grafton, Wisconsin 53024-0000, applied to be registered as a
bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Lysergic acid diethylamide.................. 7315 I
Tetrahydrocannabinols....................... 7370 I
4-Bromo-2,5-dimethoxyphenethylamine......... 7392 I
3,4-Methylenedioxyamphetamine............... 7400 I
3,4-Methylenedioxymethamphetamine........... 7405 I
5-Methoxy-N-N-dimethyltryptamine............ 7431 I
Dimethyltryptamine.......................... 7435 I
Psilocybin.................................. 7437 I
Psilocyn.................................... 7438 I
Lisdexamfetamine............................ 1205 II
Methylphenidate............................. 1724 II
Amobarbital................................. 2125 II
Nabilone.................................... 7379 II
4-Anilino-N-Phenethyl-4-Piperidine (ANPP)... 8333 II
Opium extracts.............................. 9610 II
Opium, powdered............................. 9639 II
Opium, granulated........................... 9640 II
Opium poppy................................. 9650 II
Noroxymorphone.............................. 9668 II
Fentanyl.................................... 9801 II
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for the purpose of analytical reference standards or for
sale to its customers. In reference to the drug code 7370
(Tetrahydrocannabinols), the company plans to bulk manufacture as
synthetic. No other activities for these drug codes are authorized for
this registration.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-22446 Filed 9-30-24; 8:45 am]
BILLING CODE 4410-09-P
